Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cellular & Molecular Immunology|February 23, 2022
MEF2C promotes M1 macrophage polarization and Th1 responsesXibao Zhao, Qianqian Di, Han Liu, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2023
USP39 Regulates NF-κB-Mediated Inflammatory Responses through Deubiquitinating K48-Linked IκBαJiazheng Quan, Xibao Zhao, Yue Xiao, et al.Frontiers in Endocrinology|October 25, 2021
Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced ObesityZherui Wu, Nicolas Stadler, Amazigh Abbaci, et al.Cancer Letters|August 13, 2019
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancerLudovic Fournel, Zherui Wu, Nicolas Stadler, et al.Oncotarget|September 25, 2014
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in miceSandra Dupouy, Van Kien Doan, Zherui Wu, et al.Frontiers in Immunology|July 22, 2022
Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3Xingyu Ma, Qianqian Di, Xiaoli Li, et al.Plos Biology|May 11, 2026
USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STINGJiazheng Quan, Xibao Zhao, Shaoying Chen, et al.Oncotarget|September 25, 2014
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinibMohamad Younes, Zherui Wu, Sandra Dupouy, et al.Cancer Letters|December 25, 2018
Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibodyZherui Wu, Ludovic Fournel, Nicolas Stadler, et al.Pageof 3